journal
Journals Journal of Cancer Research and...

Journal of Cancer Research and Clinical Oncology

https://read.qxmd.com/read/36971799/differences-among-a-portuguese-cohort-of-brca-pathogenic-likely-pathogenic-variants-carriers-choosing-risk-reducing-mastectomy-or-intensive-breast-surveillance
#1
JOURNAL ARTICLE
Sandra Torres, Bárbara Peleteiro, André Magalhães, Luzia Garrido, Susy Costa, José Luís Fougo
PURPOSE: Women with BRCA1 and BRCA2 (BRCA1/2) pathogenic/likely pathogenic (P/LP) variants have a higher risk to develop breast and ovarian cancer. In structured high-risk clinics, risk-reducing measures are adopted. This study aimed at characterizing these women and identify factors that may have influenced their choice between risk reduction mastectomy (RRM) and intensive breast surveillance (IBS). METHODS: This study reviewed retrospectively 187 clinical records of affected and unaffected women with P/LP variants of the BRCA1/2 genes, from 2007 to 2022, of which 50 chose RRM, while 137 chose IBS...
March 27, 2023: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/36971798/analyses-of-sex-based-clinicopathological-differences-among-patients-with-gastrointestinal-neuroendocrine-neoplasms-in-europe
#2
JOURNAL ARTICLE
Henning Jann, Sarah Krieg, Andreas Krieg, Johannes Eschrich, Tom Luedde, Karel Kostev, Sven Loosen, Christoph Roderburg
BACKGROUND: Previous studies have found variations in cancer types, tumor progression, and disease outcomes between men and women. However, there is limited knowledge of the effect of sex on gastrointestinal neuroendocrine neoplasms (GI-NENs). METHODS: We identified 1354 patients with GI-NEN from the IQVIA's Oncology Dynamics database. Patients were derived from four European countries (Germany, France, the United Kingdom (UK), Spain). Clinical and tumor related characteristics including patients' age, tumor stage, tumor grading and differentiation, frequency and sites of metastases, as well as co-morbidities were analyzed as a function of patients´ sex...
March 27, 2023: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/36971797/cytokeratin-6-identifies-basal-like-subtypes-of-pancreatic-ductal-adenocarcinoma-with-decreased-survival
#3
JOURNAL ARTICLE
Su Ir Lyu, Thaddaeus Krey, Alexander I Damanakis, Yue Zhao, Christiane J Bruns, Thomas Schmidt, Felix C Popp, Alexander Quaas, Karl Knipper
PURPOSE: Rising incidence of pancreatic ductal adenocarcinoma (PDAC) bind with insufficient therapy options showcases a great medical challenge. Further biomarkers are required to identify patients, who will benefit from more aggressive therapy. METHODS: 320 patients were included by the PANCALYZE study group. Cytokeratin 6 (CK6) immunohistochemical staining as a putative marker for the basal-like subtype of PDAC was performed. The correlation between CK6 expression patterns and survival data, as well as various markers of the (inflammatory) tumor microenvironment, were analyzed...
March 27, 2023: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/36971796/clinical-outcomes-of-immune-checkpoint-inhibitors-in-unresectable-or-metastatic-combined-hepatocellular-cholangiocarcinoma
#4
JOURNAL ARTICLE
Yoon Jung Jang, Eo Jin Kim, Hyung-Don Kim, Kyu-Pyo Kim, Min-Hee Ryu, Sook Ryun Park, Won-Mook Choi, Danbi Lee, Jonggi Choi, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Baek-Yeol Ryoo, Changhoon Yoo
PURPOSE: Immune checkpoint inhibitors (ICIs) have been demonstrated to be effective for unresectable or metastatic hepatocellular carcinoma (HCC) or cholangiocarcinoma (CCA) in prior prospective trials. However, the clinical outcomes of ICIs in patients with combined HCC-CCA (cHCC-CCA) have not been investigated. Accordingly, we retrospectively evaluated the effectiveness and safety of ICIs in patients with unresectable or metastatic cHCC-CCA. METHODS: Among 101 patients with histologically documented cHCC-CCA who received systemic therapy, 25 received ICIs between January 2015 and September 2021 and were included in the current analysis...
March 27, 2023: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/36966395/novel-nanotherapeutics-for-cancer-immunotherapy-by-ctla-4-aptamer-functionalized-albumin-nanoparticle-loaded-with-antihistamine
#5
JOURNAL ARTICLE
Fengjiao Yao, Yacong An, Xialian Lai, Xundou Li, Zhen Yu, Xian-Da Yang
INTRODUCTION: Immune checkpoint blockade (ICB) is a promising strategy for cancer treatment and has generated remarkable clinical results against multiple malignancies. Exploration of new technical approaches to further boost the therapeutic efficacy of ICB is of potential medical importance. In this study, we designed a novel nanotherapeutics for ICB immunotherapy. METHODS: CTLA-4 aptamers were conjugated to the surface of albumin nanoparticle to construct an aptamer-modified nanostructure (Apt-NP)...
March 26, 2023: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/36966394/heat-shock-protein-90-hsp90-inhibitors-in-gastrointestinal-cancer-where-do-we-currently-stand-a-systematic-review
#6
REVIEW
Christian Tibor Josef Magyar, Yogesh K Vashist, Deborah Stroka, Corina Kim-Fuchs, Martin D Berger, Vanessa M Banz
PURPOSE: Dysregulated expression of heat shock proteins (HSP) plays a fundamental role in tumor development and progression. Consequently, HSP90 may be an effective tumor target in oncology, including the treatment of gastrointestinal cancers. METHODS: We carried out a systematic review of data extracted from clinicaltrials.gov and pubmed.gov, which included all studies available until January 1st, 2022. The published data was evaluated using primary and secondary endpoints, particularly with focus on overall survival, progression-free survival, and rate of stable disease...
March 26, 2023: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/36964779/improved-exosome-isolation-methods-from-non-small-lung-cancer-cells-nc1975-and-their-characterization-using-morphological-and-surface-protein-biomarker-methods
#7
JOURNAL ARTICLE
Elham O Mahgoub, Galal M Abdella
This study has demonstrated improved methods for isolating exosomes from non-small lung cancer cells, which address the problems characterized by exosome morphological and chemical methods. To improve the isolation methods, cells from the NCI 1975 cell line were used as the source for exosomes. The isolation processes were carried out using serial isolation techniques in addition to specific preservation tools. The isolated exosomes were characterized using transmission electron microscopy (TEM), and scanning electron microscopy (SEM) was added for further assurance of the investigation results...
March 25, 2023: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/36964405/impact-of-the-covid-19-pandemic-on-reported-cancer-diagnoses-in-bavaria-germany
#8
JOURNAL ARTICLE
Sven Voigtländer, Amir Hakimhashemi, Nina Grundmann, Martin Radespiel-Tröger, Elisabeth C Inwald, Olaf Ortmann, Michael Gerken, Stefanie J Klug, Monika Klinkhammer-Schalke, Martin Meyer, Jacqueline Müller-Nordhorn
PURPOSE: The aim of our study was to explore the impact of the COVID-19 pandemic on reported cancer cases in Bavaria, Germany, by comparing pre-pandemic (March 2019 to February 2020) and pandemic period (March 2020 to February 2021). METHODS: Data on incident cases were retrieved from the Bavarian Cancer Registry (until 22nd April 2022). We included patients with malignant and in situ neoplasms reported by pathology departments with consistent reporting. We calculated the number of incident cases during the COVID-19 pandemic and the pre-pandemic period with 95% confidence intervals (CI) with Bonferroni correction (α = 0...
March 24, 2023: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/36959343/comparative-study-of-lutetium-177-and-phosphorus-32-in-radioactive-bone-cement-for-the-treatment-of-vertebral-body-metastasis
#9
JOURNAL ARTICLE
Elnaz Olyaei, Mohammad Mohammadzadeh, Parisa Azimi
BACKGROUND: Vertebroplasty is a minimally invasive outpatient procedure to stabilize compression fractures in the spine. This procedure involves injecting bone cement into the vertebrae that have been cracked or broken, typically due to osteoporosis. The cement hardens inside the bones, providing stability to the fractures and supporting the spine. Additionally, radioactive bone cement and brachytherapy sources have been utilized to suppress tumor growth in the vertebral body. OBJECTIVE: We present a novel brachytherapy technique for treating vertebral body metastases using a liquid form of radioactive sources, Phosphorus-32 and Lutetium-177, separately mixed with bone cement and injected into vertebral body bone prostheses...
March 24, 2023: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/36959342/a-case-of-rare-metachronous-four-primary-carcinoma
#10
JOURNAL ARTICLE
Yanxiang Cao
PURPOSE: When more than two tumors are diagnosed in the same person, it is called multiple primary cancer. It is rare to be diagnosed as four primary cancers. Here, we present one elderly male patient suffered from testicular seminoma, gastric cancer, bladder cancer and breast cancer from 1946 to 2019. METHODS: When he was about 1.5 years old in 1946, his mother (a doctor) inadvertently found that the left scrotum of the child was enlarged. He performed left testicular resection under general anesthesia and postoperative pathological report: left testicular seminoma...
March 24, 2023: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/36959341/gastrointestinal-stromal-tumors-of-the-upper-gi-tract-population-based-analysis-of-epidemiology-treatment-and-outcome-based-on-data-from-the-german-clinical-cancer-registry-group
#11
JOURNAL ARTICLE
Thaer S A Abdalla, Lina Pieper, Markus Kist, Michael Thomaschewski, Monika Klinkhammer-Schalke, Sylke Ruth Zeissig, Kees Kleihues-van Tol, Ulrich Friedrich Wellner, Tobias Keck, Richard Hummel
BACKGROUND: Gastrointestinal stromal tumors (GIST) are rare mesenchymal tumors. They are most frequently located in the stomach but are also found in the esophagus and the gastroesophageal junction (GEJ). Information regarding the prognostic factors associated with upper gastrointestinal GIST is still scarse. METHODS: In this study, datasets provided by the German Clinical Cancer Registry Group, including a total of 93,069 patients with malignant tumors in the upper GI tract (C15, C16) between 2000 and 2016 were analyzed to investigate clinical outcomes of GIST in the entire upper GI tract...
March 23, 2023: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/36952006/adjuvant-intravesical-treatment-in-patients-with-intermediate-and-high-risk-non-muscle-invasive-bladder-cancer-with-bcg-versus-mmc-applied-with-combat-or-emda-results-of-a-prospective-study
#12
JOURNAL ARTICLE
Miguel Ángel Arrabal Polo, María Teresa Melgarejo Segura, Yaiza Yáñez Castillo, Ana Morales Martínez, Manuel Pareja Vílchez, Miguel Arrabal Martín
BACKGROUND: Bacillus Calmette-Guerin (BCG) maintenance therapy is the standard adjuvant treatment of high- and intermediate-risk non-muscle-invasive bladder cancer (NMIBC). However, the problems of shortages and the adverse effects, both local and systemic, that it causes lead to the search for alternatives with devices that improve the penetration of intravesical chemotherapeutics. MATERIALS AND METHODS: Prospective observational study was conducted from August 2018 to August 2022...
March 23, 2023: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/36952005/comparison-of-stereotactic-body-radiotherapy-with-and-without-lenvatinib-for-advanced-hepatocellular-carcinoma-a-propensity-score-analysis
#13
JOURNAL ARTICLE
Quan Wang, Xiaoquan Ji, Jing Sun, Wengang Li, Xuezhang Duan, Aimin Zhang
PURPOSE: Lack of evidence on the benefit of stereotactic body radiotherapy (SBRT) in combination with lenvatinib for advanced hepatocellular carcinoma (HCC). Our research compared the efficacy and safety of SBRT plus lenvatinib versus SBRT alone in clinical practice for the treatment of advanced HCC. METHODS: Propensity score matching (PSM) analysis was used to reduce selection bias. Overall survival (OS), progression-free survival (PFS), intrahepatic PFS (IHPFS), and objective response rate (ORR) were compared between the two groups...
March 23, 2023: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/36949175/parasites-as-potential-targets-for-cancer-immunotherapy
#14
REVIEW
Morteza Yousefi, Mohammadesmail Akbari, Mahboubeh Hadipour, Azar Balouti Dehkordi, Zohreh Farahbakhsh, Hossein Yousofi Darani
Parasites and cancers have some common antigens. Much scientific evidence in the human population, animal models, and in vitro experiments exhibit that parasites have significant anti-cancer effects. The larval stage of the tapeworm Echinococcus granulosus, Toxoplasma gondii, Trypanosoma cruzy, Plasmodium's, and Trichinella spiralis are among the parasites that have been subjects of anti-cancer research in the last decades. Anti-tumor effects of parasites may be due to the direct impact of the parasites per se or indirectly due to the immune response raised against common antigens between malignant cells and parasites...
March 22, 2023: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/36947238/correction-to-nanotechnology-augmented-sonodynamic-therapy-and-associated-immune-mediated-effects-for-the-treatment-of-pancreatic-ductal-adenocarcinoma
#15
Marym Mohammad Hadi, Sian Farrell, Heather Nesbitt, Keith Thomas, Ilona Kubajewska, Alex Ng, Hamzah Masood, Shiv Patel, Fabiola Sciscione, Brian Davidson, John F Callan, Alexander J MacRobert, Anthony P McHale, Nikolitsa Nomikou
No abstract text is available yet for this article.
March 22, 2023: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/36947237/sumac-rose-water-mouthwash-versus-benzydamine-to-prevent-radiation-induced-oral-mucositis-in-head-and-neck-cancers-a-phase-ii-randomized-trial
#16
JOURNAL ARTICLE
Ahmad Ameri, Ghazaleh Heydarirad, Rasoul Choopani, Sanaz Poshtmahi, Pooya Ameri, Fereshteh Talebi, Anahid Bagheri Pour, Farzad Taghizadeh-Hesary
BACKGROUND: Radiation-induced oral mucositis (OM) largely impairs the quality of life (QoL) of patients with head and neck cancer (HNC). Few choices with limited efficacy are available to prevent this adverse effect. This randomized trial was conducted to compare the efficacy of benzydamine (standard) and a new combination (sumac and rose water) in preventing radiation-induced OM. METHODS: This was a phase II, triple-blind, active-controlled, randomized trial. The primary endpoint was OM, and the secondary endpoints were oral pain and QoL...
March 22, 2023: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/36944820/characterization-of-immunomodulatory-factors-and-cells-in-bronchoalveolar-lavage-fluid-for-immune-checkpoint-inhibitor-related-pneumonitis
#17
REVIEW
Peng-Mei Wang, Zhong-Wei Zhang, Shan Zhang, Qian Xing, Zhi-Yong Zhao, Qiong-Hua Lin, Li-Hua Shen, Zhi-Li Xia, Fang-Fang Li, Biao Zhu
As immune checkpoint inhibitors (ICIs) are widely used, a series of immune-related adverse events (irAEs) have been reported, including immune checkpoint inhibitor-related pneumonitis (ICI-pneumonitis). The incidence of ICI-pneumonitis is higher in reality than in clinical trials. The diagnosis is challenging, mainly based on clinical and imaging features, and requires the exclusion of other causes. The data on the biological mechanisms of ICI-pneumonitis are scarce, resulting in little knowledge of the best treatment for ICI-pneumonitis...
March 21, 2023: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/36939927/%C3%A2-concurrent-sequential-versus-sequential-immune-checkpoint-inhibition-in-inoperable-large-stage-iii-non-small-cell-lung-cancer-patients-treated-with-chemoradiotherapy-a-prospective-observational-study
#18
JOURNAL ARTICLE
Lukas Käsmann, Chukwuka Eze, Julian Taugner, Alexander Nieto, Kerstin Hofstetter, Sophie Kröninger, Julian Guggenberger, Saskia Kenndoff, Benedikt Flörsch, Amanda Tufman, Niels Reinmuth, Thomas Duell, Claus Belka, Farkhad Manapov
PURPOSE/AIM: The international standard for patients with large inoperable stage III NSCLC is durvalumab consolidation after concurrent chemoradiotherapy (CRT). In this single centre observational study based on individual data, we prospectively evaluated the role of concurrent/sequential versus sequential immune checkpoint inhibition (ICI). METHODS AND PATIENTS: In total, 39 stage III NSCLC patients were prospectively enrolled, 11 (28%) patients were treated with simultaneous and consolidation therapy with PD-1 inhibition (nivolumab) (SIM-cohort) and 28 (72%) patients received PD-L1 inhibition (durvalumab) as consolidation treatment up to 12 months after the end of CRT (SEQ-cohort)...
March 20, 2023: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/36939926/gstm1-and-gstt1-polymorphisms-associated-with-pain-in-a-chemotherapy-induced-peripheral-neuropathy-cohort
#19
JOURNAL ARTICLE
Paul J Dunn, Lyn R Griffiths, Patsy Yates, Larisa M Haupt, Kim E Alexander
PURPOSE: Chemotherapy induced peripheral neuropathy (CIPN) is a debilitating condition that is a direct consequence of receiving cancer treatment. The molecular aetiology of CIPN is not well understood, and it is theorised that there may be a genetic component. Genetic polymorphisms in Glutathione-S Transferase (GST) genes, including GSTT1, GSTM1 and GSTP1, encode for enzymes known to metabolise drugs used in chemotherapy, and have been theorised to be associated with CIPN. This study aimed to investigate four markers in these genes for an association in a mixed cancer cohort in relation to CIPN (n = 172)...
March 20, 2023: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/36939925/machine-learning-based-immune-prognostic-model-and-cerna-network-construction-for-lung-adenocarcinoma
#20
JOURNAL ARTICLE
Xiaoqian He, Ying Su, Pei Liu, Cheng Chen, Chen Chen, Haoqin Guan, Xiaoyi Lv, Wenjia Guo
PURPOSE: Lung adenocarcinoma (LUAD) is a malignant tumor with a high lethality rate. Immunotherapy has become a breakthrough in cancer treatment and improves patient survival and prognosis. Therefore, it is necessary to find new immune-related markers. However, the current research on immune-related markers in LUAD is not sufficient. Therefore, there is a need to find new immune-related biomarkers to help treat LUAD patients. METHODS: In this study, a bioinformatics approach combined with a machine learning approach screened reliable immune-related markers to construct a prognostic model to predict the overall survival (OS) of LUAD patients, thus promoting the clinical application of immunotherapy in LUAD...
March 20, 2023: Journal of Cancer Research and Clinical Oncology
journal
journal
27571
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.